1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd

000710.SZ
Berry Genomics Co.,LtdCN flagShenzhen Stock Exchange
8.05
CNY
+0.02
- -
2.85BMarket Cap

Total Valuation

Berry Genomics Co.,Ltd carries a market capitalization of 2.85B, placing it among publicly traded companies globally. Its enterprise value stands at 3.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.85B
Enterprise Value3.42B

Share Statistics

Berry Genomics Co.,Ltd currently has 353.52M shares outstanding.

Shares Outstanding353.52M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 4.96, and the price-to-book ratio stands at 17.27.

PE RatioN/A
PS Ratio4.96
PB Ratio17.27
P/TBV Ratio2.39
P/FCF Ratio67.74
P/OCF RatioN/A

Enterprise Valuation

EV / Sales5.00
EV / EBITDAN/A
EV / EBITN/A
EV / FCF59.46

Financial Position

Berry Genomics Co.,Ltd maintains a current ratio of 2.10, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 17.86, indicating elevated leverage, while an interest coverage ratio of -8.96 demonstrates limited ability to service its debt obligations.

Current Ratio2.10
Quick Ratio0.54
Debt / Equity17.86
Debt / EBITDA-4.20
Interest Coverage-8.96

Financial Efficiency

Return on Equity (ROE)-60.77
Return on Assets (ROA)-7.97
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.11

Taxes

Income Tax4.93M
Effective Tax RateN/A

Stock Price Statistics

Berry Genomics Co.,Ltd's stock has declined approximately -43.62745% over the past 52 weeks. The 50-day moving average sits at 9.04, while the 200-day moving average is 11.31.

Beta (5Y)N/A
52-Week Price Change-43.62745%
50-Day Moving Average9.04
200-Day Moving Average11.31
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Berry Genomics Co.,Ltd generated 684.05M in revenue and converted that into -184.79M in net income, yielding earnings per share of -0.56. EBITDA reached -64.32M, while operating income came in at -64.32M.

Revenue684.05M
Gross Profit295.87M
Operating Income-64.32M
Pretax Income-179.78M
Net Income-184.79M
EBITDA-64.32M
EBIT-64.32M
Earnings Per Share (EPS)-0.56

Balance Sheet

Berry Genomics Co.,Ltd holds 304.41M in cash and equivalents against 269.83M in total debt, resulting in a net debt position of -146.51M. Total book value stands at 196.62M, with working capital of 617.44M providing operational flexibility.

Cash & Cash Equivalents304.41M
Total Debt269.83M
Net Debt-146.51M
Equity (Book Value)196.62M
Book Value Per Share0.60
Working Capital617.44M

Cash Flow

After subtracting -50.12M in capital expenditures, free cash flow totaled -50.12M - equivalent to -0.15 per share.

Operating Cash FlowN/A
Capital Expenditures-50.12M
Free Cash Flow-50.12M
FCF Per Share-0.15

Margins

Berry Genomics Co.,Ltd operates with a gross margin of 43.25, reflecting its pricing power and cost economics. The operating margin of -9.40 and net profit margin of -27.01 provide insight into operational efficiency.

Gross Margin43.25
Operating Margin-9.40
Pretax Margin-26.28
Profit Margin-27.01
EBITDA Margin-9.40

Dividends & Yields

The company's payout ratio of -1.96 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.01
Dividend YieldN/A
Payout Ratio-1.96
Shareholder Yield-1.47
FCF Yield1.48

Stock Splits

Berry Genomics Co.,Ltd's most recent stock split took place on September 1, 2006 with a 50:69 split ratio.

Last Split Date9/1/2006
Split Ratio50:69

Scores

Berry Genomics Co.,Ltd posts an Altman Z-Score of 3.36, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.36